This book is a detailed and comprehensive examination of the contours of drug policy development through the consideration of the particular roles of science, media and interest groups. The author contributes to a richer understanding of the science-policy nexus in the messy, real-world complexities of drug policy, using Belgium as the primary case-study. This book will be of great value to undergraduate and graduate students, as well as to academics, practitioners and policymakers with interest in the science-policy nexus with a particular focus on the drug policy domain.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.